← Back to Search

Continuous Glucose Monitoring System

CGM Monitoring for Diabetes

N/A
Recruiting
Research Sponsored by University of the Pacific
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults 18-65 years of age
Diagnosed with Type 1 or Type 2 Diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

Study Summary

This trial looks at whether there are glucose differences between left and right arms in diabetic patients, and may identify new ways to measure glucose.

Who is the study for?
This trial is for adults aged 18-65 with Type 1 or Type 2 Diabetes who have an HbA1c level of at least 6.5, can attend virtual meetings, and are willing to wear glucose monitors on both arms without using heat therapy or consuming certain acids that affect readings. Excluded are those with skin conditions, planned imaging tests, severe needle phobia, current infections or allergies to adhesives, pregnant women, and those with implanted devices.Check my eligibility
What is being tested?
The study investigates if there's a difference in blood glucose levels when measured from the left versus right arm using Freestyle Libre 3 CGMs in diabetic patients. It aims to determine whether one side provides more consistent readings than the other.See study design
What are the potential side effects?
There may not be direct side effects from the intervention as it involves monitoring rather than medication; however, potential discomforts include skin irritation from adhesive sensors and minor bleeding or bruising where needles enter for sensor placement.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I have been diagnosed with diabetes.
Select...
I agree not to use any heat therapy while in the study.
Select...
I am not using a Freestyle Libre continuous glucose monitor.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time-matched CGM-derived blood glucose differences between left arm and right arm in patients with Type 1 or Type 2 Diabetes below target range (<70 mg/dL).
Secondary outcome measures
Time-matched CGM-derived blood glucose differences between left arm and right arm in patients above target range (>180 mg/dL).
Time-matched CGM-derived blood glucose differences between left arm and right arm in patients in target range (70-180 mg/dL).

Trial Design

1Treatment groups
Experimental Treatment
Group I: Measuring ArmExperimental Treatment1 Intervention
Participants will wear 2 Freestyle Libre 3 sensors on each arm, 1 on the left and 1 on the right for 2 consecutive weeks (total of 14 days).

Find a Location

Who is running the clinical trial?

University of the PacificLead Sponsor
13 Previous Clinical Trials
726 Total Patients Enrolled

Media Library

Freestyle Libre 3 (Continuous Glucose Monitoring System) Clinical Trial Eligibility Overview. Trial Name: NCT05849428 — N/A
Type 2 Diabetes Research Study Groups: Measuring Arm
Type 2 Diabetes Clinical Trial 2023: Freestyle Libre 3 Highlights & Side Effects. Trial Name: NCT05849428 — N/A
Freestyle Libre 3 (Continuous Glucose Monitoring System) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05849428 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any openings available for those wishing to participate in this experiment?

"As per the most recent update on clinicaltrials.gov, this study is actively enrolling patients. The posting date was May 1st 2023 and it underwent its newest revision on April 28th of the same year."

Answered by AI

Does the eligibility criteria for this trial include those aged 40 or above?

"This clinical trial has an age limit of 18 to 65 years old. Additionally, there are a total of 224 trials available for minors and 1170 studies which cater to those above the senior cutoff."

Answered by AI

How many research participants are currently being monitored for this investigation?

"Affirmative. Clinicaltrials.gov attests to the fact that this research study is in search of volunteers, having been first posted on May 1st 2023 and recently revised on April 28th 2023. Specifically, 10 participants need to be enrolled at one site."

Answered by AI

What is the eligibility criterion to participate in this trial?

"To partake in this medical study, individuals must possess type 1 diabetes and be between the ages of 18-65. This clinical trial is accepting 10 participants in total."

Answered by AI

Who else is applying?

What site did they apply to?
University of the Pacific
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

Recent research and studies
clinicaltrials.govStudy
Blood Glucose Differences Using CGMs Between the Left and Right Arm in Patients With Diabetes
Sachin Shah 2023. "Blood Glucose Differences Using CGMs Between the Left and Right Arm in Patients With Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05849428.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top